High-Content and Phenotypic Screening Europe 2018 (Cambridge, United Kingdom - May 24-25, 2018)

  • ID: 4495420
  • Conference
  • Location: Cambridge, United Kingdom
  • 2 Days
  • Select Biosciences
  • Conference Dates: May 24-25, 2018
1 of 4

High-Content & Phenotypic Screening 2018 is part of the event organisers, Innovations in Drug Discovery 2018 Conference to be held in Cambridge, UK.

This conference held co-located and concurrently with Stem Cells in Drug Discovery 2018 and Antibodies in Drug Discovery 2018 explores the emerging trends and technologies impacting Drug Discovery, circa 2018.

The conference content and presentations are intertwined and delegates and exhibitors receive full access to both tracks.

This conference brings together researchers from both academia and industry, and will discuss the development of techniques and tools implemented in High-Content technologies and Phenotypic Screening applications.

Topics to be covered include 3D-cell based screening methods, high content screening and data management, the use of model organisms and novel approaches for phenotypic screening.

Attending this event will provide you with excellent opportunities for networking with attendees from big pharmaceutical and biotech companies, academia and technology/tools vendors, helping you to find solutions and build collaborations.

*Please note: events may be cancelled due to commercial or organisational reasons. In this case Research and Markets will refund all registration fees which have already been paid. Research and Markets will not refund any charges arising from the participant having to cancel or re-book transportation or accommodation which he or she has arranged.

Note: Product cover images may vary from those shown
2 of 4
  • High-Content Analysis and Phenotypic Screening for New Targets
  • Image Analysis and Data Management Tools
  • Phenotypic and High Content Screening of 3D-Model Systems
  • Phenotypic Drug Discovery
Note: Product cover images may vary from those shown
3 of 4


4 of 4

Keynote Speakers

David Hay
Professor, University of Edinburgh

Paul French
Professor, Department of Physics and Photonics Group, Imperial College London

Robert Williams
Chief Drug Development Scientist, Cancer Research UK

Stefan Dubel
Full Professor and Director, Technische Universität Braunschweig

Matthew Daniels
Wellcome Trust Intermediate Clinical Fellow, Honorary Consultant Cardiologist, University of Oxford

Gary Gintant
Research Fellow, Abbvie

Stephen Helliwell
Senior Investigator, Novartis Institutes for BioMedical Research

Confirmed Speakers to Date

Louise Affleck
UK Team Leader, Cisbio Bioassays

Hugh Byrne
Professor, Dublin Institute of Technology

Win-Yan Chan
Research Scientist, UCB

Jacqueline Chuah
Lab Officer, Institute of Bioengineering and Nanotechnology, A*Star

Maciej Daniszewski
PhD Student, University of Melbourne

Nicholas Hannan
Assistant Professor, University of Nottingham

Ben Haworth
Cellular Imaging Application Specialist, GE Life Sciences

Peter Horvath
Finnish Distinguished Professor, Fellow FIMM Helsinki and Group Leader, Hungarian Academia of Sciences

Simon Hufton
Section Head Molecular Immunology, National Institute for Biological Standard and Control (NIBSC)

Hua Rong Lu
Senior Principal Scientist, Discovery Sciences, Janssen Pharmaceutical NV

Peter O'Brien
Head of Clinical Pathology, University College Dublin

Alice Pébay
Associate Professor, Principal Research Fellow, University of Melbourne & Centre for Eye Research Australia

Sanjay Sinha
BHF Senior Research Fellow, University of Cambridge

Masatoshi Suzuki
Associate Professor, Department of Comparative Biosciences and Stem Cell & Regenerative Medicine Center, University of Wisconsin-Madison

E. Sally Ward
Professor, Texas A&M University Health Science Center

Joanne Young
Senior Scientist, CYTOO SA

Note: Product cover images may vary from those shown
5 of 4


Westminster College
Madingley Road
United Kingdom

Note: Product cover images may vary from those shown